References
- Rohde LE, Polanczyk CA, Goldman L, Cook EF, Lee RT, Lee TH. Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol 2001;87:505-509. https://doi.org/10.1016/S0002-9149(00)01421-1
- Halm EA, Browner WS, Tubau JF, Tateo IM, Mangano DT. Echocardiography for assessing cardiac risk in patients having noncardiac surgery: Study of Perioperative Ischemia Research Group. Ann Intern Med 1996;125:433-441. https://doi.org/10.7326/0003-4819-125-6-199609150-00001
- Kertai MD, Poldermans D, Bax JJ, Klein J, Van Urk H. Cardiac risk and perioperative management. J Cardiovasc Surg (Torino) 2003;44:431-435.
- Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167. https://doi.org/10.1056/NEJMoa020233
- McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13. https://doi.org/10.1016/S0140-6736(97)03034-1
- Wu AH, Packer M, Smith A, et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004;50:867-873. https://doi.org/10.1373/clinchem.2003.026138
- Rodseth RN, Lurati Buse GA, Bolliger D, et al. The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events: an individual patient data meta-analysis. J Am Coll Cardiol 2011;58:522-529. https://doi.org/10.1016/j.jacc.2011.04.018
- Ryding AD, Kumar S, Worthington AM, Burgess D. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology 2009;111:311-319. https://doi.org/10.1097/ALN.0b013e3181aaeb11
- Cuthbertson BH, Card G, Croal BL, McNeilly J, Hillis GS. The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery. Anaesthesia 2007;62:875-881. https://doi.org/10.1111/j.1365-2044.2007.05146.x
- Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2010;27:92-137.
- Yun KH, Park EM, Kim YK, et al. Usefulness of the measurement of the plasma NT-ProBNP level for the prediction of the postoperative cardiac risk in elderly patients. Korean J Med 2005;68:39-46.
- Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969. https://doi.org/10.1016/S0735-1097(00)00804-4
- Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-1049. https://doi.org/10.1161/01.CIR.100.10.1043
- Takase B, Younis LT, Byers SL, et al. Comparative prognostic value of clinical risk indexes, resting two-dimensional echocardiography, and dipyridamole stress thallium-201 myocardial imaging for perioperative cardiac events in major nonvascular surgery patients. Am Heart J 1993;126:1099-1106. https://doi.org/10.1016/0002-8703(93)90660-2
- Gordon AJ, Macpherson DS. Guideline chaos: conflicting recommendations for preoperative cardiac assessment. Am J Cardiol 2003;91:1299-1303. https://doi.org/10.1016/S0002-9149(03)00317-5
- Feringa HH, Schouten O, Dunkelgrun M, et al. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery. Heart 2007;93:226-231.
- Hammerer-Lercher A, Puschendorf B, Mair J. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients. Clin Lab 2001;47:265-277.
- Rodeheffer RJ. Measuring plasma B-type natriuretic peptide in heart failure: good to go in 2004? J Am Coll Cardiol 2004;44:740-749.
- De Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-1021. https://doi.org/10.1056/NEJMoa011053
- Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003;107:2786-2792. https://doi.org/10.1161/01.CIR.0000070953.76250.B9
- Mega JL, Morrow DA, De Lemos JA, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRETIMI-23 substudy. J Am Coll Cardiol 2004;44:335-339. https://doi.org/10.1016/j.jacc.2004.04.033
- Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002;105:595-601. https://doi.org/10.1161/hc0502.103010
- Kerola T, Hiltunen M, Kettunen R, et al. Mini-Mental State Examination score and B-type natriuretic peptide as predictors of cardiovascular and total mortality in an elderly general population. Ann Med 2011;43:650‐659. https://doi.org/10.3109/07853890.2010.526137
- Manzano L, Escobar C, Cleland JG, Flather M. Diagnosis of elderly patients with heart failure. Eur J Heart Fail 2012;14:1097-1103. https://doi.org/10.1093/eurjhf/hfs109
- Park SJ, Choi JH, Cho SJ, et al. Comparison of transthoracic echocardiography with N-terminal pro-brain natriuretic peptide as a tool for risk stratification of patients undergoing major noncardiac surgery. Korean Circ J 2011;41:505-511. https://doi.org/10.4070/kcj.2011.41.9.505
- Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis 2002;44:293-321. https://doi.org/10.1053/pcad.2002.24599